Interview with Veteran HIV Prevention and Social Justice Activist Julie Davids In December 2010, TAGlinecaught up with the super energetic and visionary HIV activist Julie Davids, veteran of ACT UP/Philadelphia, HealthGAP, and a slew of more recent U.S. HIV prevention…
By Richard Jefferys In Vienna, Austria, on July 16 and 17, 2010, immediately prior to the XVIII International AIDS Conference, the International AIDS Society (IAS) held a workshop titled “Towards a Cure: HIV Reservoirs and Strategies to Control Them.” Cosponsors…
The search for a cure for HIV has recently been given fresh impetus by the widely reported case of an HIV-positive individual named Timothy Brown who has remained free of detectable virus for four years (and counting) after a complex…
Letter from TAG and other signatories calling on all governments, donors, international agencies, researchers, implementers and civil society to act to end the AIDS epidemic now.
HIV, Hepatitis C Virus (HCV), and Tuberculosis Drugs, Diagnostics, Vaccines, and Preventive Technologies in Development Second Edition September 2011 Written by Polly Clayden, Simon Collins, Mark Harrington, Richard Jefferys, Tracy Swan, Javid Syed, and Claire Wingfield with a a contribution…
July 2011 - Investments in health research at the National Institutes of Health (NIH) have paid enormous dividends in the health and well-being of people in the U.S. and around the world. HIV and AIDS research supported by NIH has…
July 2011 - In 2010, the number of people receiving ART grew by 1.3 million from 5.3 to 6.6 million. Yet, 2.6 million new infections and 1.8 million AIDS deaths occurred. New infections continue to outpace the number of people…
Data collected for the first time on global investments in HIV treatment-related research and development showed that at least US$ 2.46 billion was available in 2009. The Treatment Action Group, AVAC, and the Joint United Nations Programme on HIV/AIDS (UNAIDS) issued the report which was released at the International AIDS Society's 6th Conference on HIV Pathogenesis, Prevention, and Treatment in Rome, Italy.
The new drug, diagnostic, and vaccine pipeline has never looked more promising for people with HIV, hepatitis C virus (HCV), and tuberculosis (TB), according to a report released today by Treatment Action Group (TAG) and HIV i-Base.
TAG Statement on the U.N. High Level Meetings on HIV/AIDS Outcome Document.